Highest-Volume Intravitreal Injection (Anti-VEGF) Surgeons in Massachusetts (2026 update)
129 Massachusetts providers billed Medicare for Intravitreal Injection (Anti-VEGF) (CPT 67028) in 2024. The top 10 by case volume are below — the full ranked list, CSV export and competitor-payment intel are available with a DocVol subscription ($199/mo, cancel anytime).
Database refreshed July 2026Live NPPES registryⓘ sources
| # | Surgeon | Location | Medicare cases (2024) |
|---|---|---|---|
| 1 | Babak Jian Seyedahmadi, M.D. | East Weymouth, MA | 6,298 |
| 2 | David Reed, M.D. | Plymouth, MA | 5,328 |
| 3 | Torsten Wiegand, MD | Boston, MA | 4,361 |
| 4 | Chirag Shah, MD | Boston, MA | 3,337 |
| 5 | Miriam Englander-Paschalis Ilios, M.D. | Boston, MA | 2,796 |
| 6 | Jeffrey Heier | Boston, MA | 2,382 |
| 7 | Howard Ying, M.D.,PH.D. | Cambridge, MA | 2,378 |
| 8 | Namrata Nandakumar, MD | Peabody, MA | 2,138 |
| 9 | Adam Chin, M.D. | Boston, MA | 2,091 |
| 10 | Andrew Lam, M.D. | Springfield, MA | 2,047 |
119 more Massachusetts surgeons in the full list
Plus: who already pays them (Stryker? Medtronic? Arthrex?), CSV export for your CRM, and every other state and procedure.
Search the full databaseFrequently asked questions
- How many surgeons perform Intravitreal Injection (Anti-VEGF) in Massachusetts?
- 129 Massachusetts providers billed Medicare for Intravitreal Injection (Anti-VEGF) (CPT 67028) in CY2024. CMS suppresses providers with 10 or fewer Medicare patients, so the true count is somewhat higher.
- Where does this data come from?
- CMS Medicare Physician & Other Practitioners (fee-for-service Part B claims, CY2024, released May 2026) and CMS Open Payments. Both are official U.S. federal datasets.
- Does this include all of a surgeon's cases?
- No — it covers traditional Medicare only (no Medicare Advantage, commercial, or Medicaid claims). Absolute volumes undercount total practice, but the ranking of high- vs low-volume surgeons is a strong targeting signal.